Atrial Fibrillation

ICER, New England CEPAC

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the US population. AF occurs when rapid, disorganized electrical signals cause the atria (the two upper chambers of the heart) to “fibrillate”, or contract quickly and irregularly. This in turn causes some blood to pool in the atria rather than be pumped completely into the ventricles. AF can be asymptomatic but it may also be associated with several bothersome symptoms, including shortness of breath, difficulty with exercise, palpitations, general fatigue, dizziness, and confusion.

Interventions of interest:

Antiarrhythmic drugs (amiodarone, dronedarone)
Catheter ablation
Surgical ablation

Date of review: June 2011


Interventions of interest:

Antiarrhythmic drug therapy to return the heart to sinus rhythm
Radiofrequency catheter ablation to terminate AF and prevent further episodes
Minimally-invasive surgical techniques to terminate AF and prevent further episodes
Aspirin, warfarin, and dabigatran for anticoagulation to prevent strokes
The WATCHMAN left atrial appendage occlusive device to prevent strokes

Date of review: September 2010

 

For questions or additional information, please contact info@icer-review.org

ASSOCIATED MEETING & MATERIALS

New England CEPAC
June 11, 2011 10:00AM-3:30PM

 

Boston, MA

Key Dates

Associated Materials


Key Dates

Associated Materials